Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-046481

Chief Financial Officer sold 20,000 shares at $37.78 ($755,600)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-08-10 Option exercise +20,000 $6.32 $126,400 21,000 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2020-08-10 Sale −20,000 $37.78 $755,600 1,000 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $37.78 · $755,600

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-08-10 Option exercise · Stock Option (Right To Buy) −20,000 620,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…